换一批
换一批摘要篇首： Although renal grafts' survival and functioning have been improved with the introduction of cyclosporine A (CsA) into the immunosuppression treatment, its long-term results are still failing to meet treatment expectations. One of the important reasons is that the bioavailability of CsA varies largely among different patients but the use of CsA is not individualized.
更多相关知识
分类号
R3
发布时间
2006-03-02
- 浏览72
- 被引4
- 下载0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
